A scientific review board has closed down the oral tenofovir arm of the Vaginal and Oral Interventions to Control the Epidemic (VOICE) study looking at pre-exposure prophylaxis (PrEP) HIV prevention interventions among women in Africa. The Microbicides Trial Network, responsible for the study, made the announcement Wednesday. VOICE is the first study to compare the […]
The House Appropriations Committee posted a draft bill today funding the Departments of Labor, Health and Human Services and Education programs. The draft contains a $1 billion increase for biomedical research for a total of $31.7 billion at the National Institutes of Health (NIH), but eliminates $300 million in funding for the Global Fund to […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]